This website uses first-party and third-party cookies to enhance our services and show you information related to your preferences by analysing your browsing habits. By continuing to browse our website you accept our use of cookies. You can change the settings or get more information by visiting our Cookies Policy.

European approval as class III medical device: 

  • TASECTAN DUO® is intended to restore the physiological function of the intestinal wall as well as to prevent and alleviate dysbacteriosis of different nature and origin.
  • TASECTAN DUO® is indicated for the prevention and treatment of digestive disorders as diarrhoea and other related symptoms such as bloating and abdominal tension, as a result of infectious gastroenteritis, antibiotic treatments and chemotherapy among others, being effective within the first 12 hours. TASECTAN DUO® contributes to restore the optimal gut conditions to promote growth of the endogenous intestinal flora thus contributing to improve the natural defenses of the organism.

TASECTAN DUO® is available in powder sachets for paediatric use and tablets for adults use. TASECTAN DUO® is already marketed in European countries.

       
This area contains information intended exclusively for health professionals authorized to prescribe or dispense pharmaceutical products.
   
Calle Consejo de Ciento, 333
08007 Barcelona, Spain

Contact us

info@noventure.com
NOVENTURE S.L.
Tel: +34.93.205.27.18